MGNX Chart
- 52-Week Range: $3.90 - $32.34
- Market Capitalization: $244.11M
- Short Percentage: 0%
- Target Price: $28.33
- Shares Outstanding: 61.33M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MGNX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- MacroGenics Announces Appointment of William Heiden to Board of DirectorsGlobeNewsWire | May 23rd
- MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 3rd
- MacroGenics Announces Date of First Quarter 2022 Financial Results Conference CallGlobeNewsWire | April 25th
- MacroGenics, Inc. (MGNX) CEO Scott Canning on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- MacroGenics Announces Date of Fourth Quarter 2021 Financial Results Conference CallGlobeNewsWire | February 14th
- MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 3rd
- MacroGenics Shares Fall After MGC018 Data Fails To Impress At ESMO PresentationBenzinga | September 16th
- MacroGenics Announces Presentations at ESMO 2021 Virtual Annual CongressGlobeNewsWire | September 12th
Company Info
Website: https://www.macrogenics.com
Address: 9704 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 427
Address: 9704 Medical Center Drive, Rockville, MD, United States, 20850
Sector: Healthcare
Industry: Biotechnology
Full time employees: 427
$MGNX Overpower the algos!
$MGNX Shorts talk the talk but cant walk the walk
$MGNX is the dump over
$MGNX we finna be at the top yo
$MGNX no pain no gain
$MGNX Powell save me
$MGNX they don’t want us to shine… But we gon shine…
$MGNX the bulls in here
$MGNX who here can't stand the CEO?
$MGNX has just been halted from trading.